These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6363192)

  • 1. [Rifamycin].
    Acocella G
    G Ital Chemioter; 1983; 30(1):1-24. PubMed ID: 6363192
    [No Abstract]   [Full Text] [Related]  

  • 2. New rifamycins. II. Synthesis and biological activity of oximes, hydrazones, and semicarbazones of 3-N-(piperidin-4-one)rifamycin S.
    Marsili L; Franceschi G; Galliani C; Sanfilippo A; Vigevani A
    Farmaco Sci; 1982 Dec; 37(12):781-6. PubMed ID: 7152013
    [No Abstract]   [Full Text] [Related]  

  • 3. Novel rifamycins. I-Synthesis and antibacterial activity of 3-hydrazinorifamycin derivatives.
    Marsili L; Franceschi G; Gioia B; Oronzo G; Schioppacassi G; Vigevani A
    Farmaco Sci; 1982 Oct; 37(10):641-50. PubMed ID: 6814953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent trends in rifamycin research.
    Lal R; Lal S
    Bioessays; 1994 Mar; 16(3):211-6. PubMed ID: 7513153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rifamycins: a general view.
    Riva S; Silvestri LG
    Annu Rev Microbiol; 1972; 26():199-224. PubMed ID: 4562808
    [No Abstract]   [Full Text] [Related]  

  • 6. [Intermittent in the treatment with rifamycin in tuberculosis].
    Lewit T; Terracina S; Karman S
    Harefuah; 1972 Sep; 83(5):194-5. PubMed ID: 4652886
    [No Abstract]   [Full Text] [Related]  

  • 7. [Experience in the clinical use of rifamycin SV].
    Govorovich EA; Marshak AM; Iakovlev VP
    Antibiotiki; 1972 Nov; 17(11):1022-5. PubMed ID: 4664262
    [No Abstract]   [Full Text] [Related]  

  • 8. Chemical modification of the amide group of rifamycin S.
    Taguchi M; Tsukamoto G
    Chem Pharm Bull (Tokyo); 1985 May; 33(5):2133-6. PubMed ID: 4053236
    [No Abstract]   [Full Text] [Related]  

  • 9. [Value of rifamycin sv used in situ in urologic surgery].
    Patoir G; Lemaire G
    Lille Med; 1976 Jan; 21(1 suppl 1):8-12. PubMed ID: 1256231
    [No Abstract]   [Full Text] [Related]  

  • 10. Rifamycin lavage in the treatment of experimental intra-abdominal infection.
    Jallouli M; Hakim A; Znazen A; Sahnoun Z; Kallel H; Zghal K; Hammami A; Mhiri R
    J Surg Res; 2009 Aug; 155(2):191-4. PubMed ID: 19535094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New long-acting 3-azinomethyl-rifamycins.
    Bruzzese T; Cedro A; Dell'Acqua E; Di Nardo A; Goi A
    Farmaco Sci; 1986 Mar; 41(3):196-204. PubMed ID: 3709786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid disappearance from the intestinal tract of bacteria resistant to rifaximin.
    De Leo C; Eftimiadi C; Schito GC
    Drugs Exp Clin Res; 1986; 12(12):979-81. PubMed ID: 3569008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New rifamycins modified at positions 3 and 4. Synthesis, structure and biological evaluation.
    Marsili L; Pasqualucci CR; Vigevani A; Gioia B; Schioppacassi G; Oronzo G
    J Antibiot (Tokyo); 1981 Aug; 34(8):1033-8. PubMed ID: 7319919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early intermediates in the biosynthesis of ansamycins. I. Isolation and identification of protorifamycin I.
    Ghisalba O; Traxler P; Nüesch J
    J Antibiot (Tokyo); 1978 Nov; 31(11):1124-31. PubMed ID: 721708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on quantitative structure-activity relationships. V. QSAR investigations of rifamycin B amides and hydrazides by utilization of the substituent entropy constant sigma s degrees.
    Kawaki H; Takagi T; Sasaki Y
    Chem Pharm Bull (Tokyo); 1983 Jan; 31(1):144-8. PubMed ID: 6850931
    [No Abstract]   [Full Text] [Related]  

  • 16. [Ansamycins].
    Maslin DN
    Antibiotiki; 1979 Jul; 24(7):535-57. PubMed ID: 37801
    [No Abstract]   [Full Text] [Related]  

  • 17. Biosynthetic and semisynthetic rifamycins.
    Sensi P
    Postepy Hig Med Dosw; 1972; 26(4):509-21. PubMed ID: 4635069
    [No Abstract]   [Full Text] [Related]  

  • 18. A novel degradation of rifamycin: isolation of the new ansa chain derivative from rifampicin.
    Kinoshita M; Tatsuta K; Nakata M
    J Antibiot (Tokyo); 1978 Jun; 31(6):630-1. PubMed ID: 681247
    [No Abstract]   [Full Text] [Related]  

  • 19. Rifamycin SV in the local treatment of synovitis.
    Caruso I
    J Rheumatol; 1987 Feb; 14(1):178-9. PubMed ID: 3572924
    [No Abstract]   [Full Text] [Related]  

  • 20. 4-Deoxypyrido[1',2':1,2]imidazo[5,4-c]rifamycin SV derivatives. A new series of semisynthetic rifamycins with high antibacterial activity and low gastroenteric absorption.
    Marchi E; Montecchi L; Venturini AP; Mascellani G; Brufani M; Cellai L
    J Med Chem; 1985 Jul; 28(7):960-3. PubMed ID: 4009619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.